Meitav Investment House Ltd. Has $3.99 Million Holdings in CME Group Inc. $CME

Key Points

• Meitav Investment House Ltd. significantly increased its holdings in CME Group Inc. by 332.5% during the 2nd quarter, resulting in a total valuation of approximately $3.99 million.
• CME Group reported an earnings per share (EPS) of $2.96 for the latest quarter, surpassing analysts’ expectations, with a revenue increase of 10.4% year-over-year.
• The company's quarterly dividend of $1.25 per share represents an annualized yield of 1.9% and a payout ratio of 48.40%.

Meitav Investment House Ltd. lifted its position in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 332.5% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 14,485 shares of the financial services provider's stock after acquiring an additional 11,136 shares during the quarter. Meitav Investment House Ltd.'s holdings in CME Group were worth $3,991,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of CME. Webster Bank N. A. raised its position in CME Group by 206.9% in the second quarter. Webster Bank N. A. now owns 89 shares of the financial services provider's stock valued at $25,000 after purchasing an additional 60 shares during the last quarter. Highline Wealth Partners LLC increased its stake in shares of CME Group by 84.3% in the second quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider's stock valued at $26,000 after buying an additional 43 shares during the period. Wayfinding Financial LLC bought a new position in CME Group in the 1st quarter valued at approximately $25,000. Cornerstone Planning Group LLC boosted its position in CME Group by 122.2% during the 1st quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider's stock worth $26,000 after buying an additional 55 shares during the period. Finally, Golden State Wealth Management LLC grew its holdings in CME Group by 612.5% during the 1st quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider's stock worth $30,000 after acquiring an additional 98 shares during the last quarter. Institutional investors own 87.75% of the company's stock.

CME Group Stock Down 1.0%

Shares of CME Group stock opened at $262.05 on Tuesday. The stock's 50-day moving average is $269.74 and its 200 day moving average is $271.16. CME Group Inc. has a one year low of $213.94 and a one year high of $290.79. The firm has a market cap of $94.44 billion, a price-to-earnings ratio of 25.37, a PEG ratio of 5.57 and a beta of 0.41. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.91 by $0.05. The firm had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.68 billion. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The company's revenue was up 10.4% compared to the same quarter last year. During the same period in the previous year, the firm earned $2.56 earnings per share. Equities research analysts anticipate that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Investors of record on Tuesday, September 9th were paid a dividend of $1.25 per share. The ex-dividend date of this dividend was Tuesday, September 9th. This represents a $5.00 annualized dividend and a yield of 1.9%. CME Group's dividend payout ratio is currently 48.40%.

Insider Activity at CME Group

In other CME Group news, insider Sunil Cutinho sold 11,896 shares of CME Group stock in a transaction on Tuesday, August 26th. The shares were sold at an average price of $271.47, for a total value of $3,229,407.12. Following the completion of the sale, the insider directly owned 17,440 shares of the company's stock, valued at approximately $4,734,436.80. The trade was a 40.55% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, General Counsel Jonathan L. Marcus sold 392 shares of the stock in a transaction dated Thursday, September 18th. The stock was sold at an average price of $262.00, for a total transaction of $102,704.00. Following the transaction, the general counsel directly owned 7,851 shares in the company, valued at $2,056,962. This trade represents a 4.76% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 13,043 shares of company stock valued at $3,527,956. Company insiders own 0.30% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the stock. Morgan Stanley raised their price target on shares of CME Group from $303.00 to $312.00 and gave the company an "overweight" rating in a research note on Wednesday, October 1st. Barclays set a $298.00 target price on CME Group and gave the stock an "equal weight" rating in a research report on Thursday, July 24th. Citigroup raised CME Group from a "neutral" rating to a "buy" rating and lifted their target price for the stock from $275.00 to $300.00 in a report on Thursday, September 25th. Piper Sandler increased their price target on CME Group from $283.00 to $296.00 and gave the company an "overweight" rating in a research note on Tuesday, July 15th. Finally, Oppenheimer lifted their price objective on CME Group from $300.00 to $303.00 and gave the stock an "outperform" rating in a research note on Thursday, July 24th. Six equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat, CME Group presently has an average rating of "Hold" and a consensus target price of $274.15.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.